Molecular mechanisms of in vitro betulin-induced apoptosis of Leishmania donovani

American Journal of Tropical Medicine and Hygiene

Volumn 90, Issue 2, 2014, Pages 354-360

  Saudagar, Prakash ^a   Dubey, Vikash Kumar ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY GUWAHATI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BETULIN; CASPASE; LIPOCORTIN 5; REACTIVE OXYGEN METABOLITE;

ANTIPROTOZOAL ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG STRUCTURE; FLOW CYTOMETRY; IN VITRO STUDY; LEISHMANIA DONOVANI; LEISHMANIASIS; MACROPHAGE; MEMBRANE DAMAGE; MITOCHONDRIAL MEMBRANE; NONHUMAN; PROMASTIGOTE;

ANTIPROTOZOAL AGENTS; APOPTOSIS; DNA FRAGMENTATION; DNA, PROTOZOAN; ELECTROPHORESIS, AGAR GEL; HUMANS; LEISHMANIA DONOVANI; MACROPHAGES; MEMBRANE POTENTIAL, MITOCHONDRIAL; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; TRITERPENES;

EID: 84893436814     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.13-0320     Document Type: Article

References (40)

1. Olivier M, Gregory DJ, Forget G, 2005. Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view. Clin Microbiol Rev 18: 293-305. (Pubitemid 40548295)
2. Kaye PM, Aebischer T, 2011. Visceral leishmaniasis: immunology and prospects for vaccine. Clin Microbiol Infect 17: 1462-1470.
3. Selvapandiyan A, Duncan R, Debrabant A, Lee N, Sreenivas G, Salotra P, Nakhasi HL, 2006. Genetically modified live attenuated parasites as vaccines for leishmaniasis. Indian J Med Res 123: 455-466. (Pubitemid 43905582)
4. Solomon M, Pavlotsky F, Leshem E, 2011. Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica. J Eur Acad Dermatol Venereol 25: 973-977.
5. Wortmann G, Zapor M, Ressner R, Fraser S, Hartzell J, Pierson J, Weintrob A, Magill A, 2010. Lipsosomal amphotericin B for treatment of cutaneous leishmaniasis. Am J Trop Med Hyg 83: 1028-1033.
6. Mishra M, Biswas UK, Jha DN, Khan AB, 1992. Amphotericin versus pentamidine in antimony-unresponsive kala-azar. Lancet 340: 1256-1257.
7. Sindermann H, Engel J, 2006. Development of miltefosine as an oral treatment for leishmaniasis. Trans R Soc Trop Med Hyg 100: S17-S20. (Pubitemid 44490164)
8. Seifert K, Perez-Victoria FJ, Stettler M, Sánchez-Cañete MP, Castanys S, Gamarro F, Croft SL, 2007. Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo. Int J Antimicrob Agents 30: 229-235. (Pubitemid 47135625)
9. Lillig CH, Holmgren A, 2007. Thioredoxin and related molecules- from biology to health and disease. Antioxid Redox Signal 9: 25-47. (Pubitemid 44901873)
10. Krauth-Siegel RL, Leroux AE, 2012. Low-molecular-mass antioxidants in parasites. Antioxid Redox Signal 17: 583-607.
11. Krauth-Siegel RL, Comini MA, 2008. Redox control in trypanosomatids, parasitic protozoa with trypanothione-based thiol metabolism. Biochim Biophys Acta 1780: 1236-1248.
12. Dormeyer M, Reckenfelderbaumer N, Ludemann H, Krauth-Siegel RL, 2001. Trypanothione-dependent synthesis of deoxyribonucleotides by Trypanosoma brucei ribonucleotide reductase. J Biol Chem 276: 10602-10606. (Pubitemid 38094248)
13. Krauth-Siegel RL, Lüdemann H, 1996. Reduction of dehydroascorbate by trypanothione. Mol Biochem Parasitol 80: 203-208. (Pubitemid 26313383)
14. Flohe L, Hecht HJ, Steinert P, 1999. Glutathione and trypanothione in parasitic hydroperoxide metabolism. Free Radic Biol Med 27: 966-984. (Pubitemid 29507470)
15. Comini MA, Guerrero SA, Haile S, Menge U, Lünsdorf H, Flohé L, 2004. Validation of Trypanosoma brucei trypanothione synthetase as drug target. Free Radic Biol Med 36: 1289-1302. (Pubitemid 38526323)
16. Ariyanayagam MR, Oza SL, Guther ML, Fairlamb AH, 2005. Phenotypic analysis of trypanothione synthetase knockdown in the African trypanosome. Biochem J 39: 425-432. (Pubitemid 41532441)
17. Saudagar P, Dubey VK, 2011. Cloning, expression, characterization and inhibition studies on trypanothione synthetase, a drug target enzyme, from Leishmania donovani. Biol Chem 392: 1113-1122.
18. Reutrakul V, Anantachoke N, Pohmakotr M, Jaipetch T, Yoosook C, Kasisit J, Napaswa C, Panthong A, Santisuk T, Prabpai S, Kongsaeree P, Tuchinda P, 2010. Anti-HIV-1 and anti-inflammatory lupanes from the leaves, twigs, and resin of Garcinia hanburyi. Planta Med 76: 368-371.
19. Steele JC, Warhurst DC, Kirby GC, Simmonds MS, 1999. In vitro and in vivo evaluation of betulinic acid as an antimalarial. Phytother Res 13: 115-119. (Pubitemid 29129443)
20. Laszczyk MN, 2009. Pentacyclic triterpenes of the lupane, oleanane and ursane group as tools in cancer therapy. Planta Med 75: 1549-1560.
21. Li Y, He K, Huang Y, Zheng D, Gao C, Cui L, Jin YH, 2010. Betulin induces mitochondrial cytochrome c release associated apoptosis in human cancer cells. Mol Carcinog 49: 630-640.
22. Chowdhury S, Mukherjee T, Sengupta S, Chowdhury SR, Mukhopadhyay S, Majumder HK, 2011. Novel Betulin derivatives as antileishmanial agents with mode of action targeting type Ib DNA topoisomerase. Mol Pharmacol 80: 694-703.
23. Mosmann T, 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63. (Pubitemid 14203433)
24. Shukla AK, Patra S, Dubey VK, 2012. Iridoid glucosides from Nyctanthes arbortristis result in increased reactive oxygen species and cellular redox homeostasis imbalance in Leishmania parasite. Eur J Med Chem 54: 49-58.
25. Shukla AK, Patra S, Dubey VK, 2011. Evaluation of selected antitumor agents as subversive substrate and potential inhibitor of trypanothione reductase: an alternative approach for chemotherapy of leishmaniasis. Mol Cell Biochem 352: 261-270.
26. Sambrook J, Fritsch EF, Maniatis T, 1989. Molecular Cloning: A Laboratory Manual. Second edition. New York: Cold Spring Harbor Laboratory, 5.61-5.64.
27. Boonstra J, Post JA, 2004. Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells. Gene 337: 1-13. (Pubitemid 38970100)
28. Sen N, Das BB, Gangulyet A, Mukherjee T, Tripathi G, Bandyopadhyay S, Rakshit S, Sen T, Majumder HK, 2004. Camptothecin-induced mitochondrial dysfunction leading to programmed cell death in unicellular hemoflagellate Leishmania donovani. Cell Death Differ 11: 924-936. (Pubitemid 39139751)
29. Roy A, Ganguly A, Dasgupta SB, Das BB, Pal C, Jaisankar P, Majumder HK, 2008. Mitochondria dependent reactive oxygen species mediated programmed cell death induced by 3,3-di indolylmethane through inhibition of F0F1-ATP synthase in unicellular protozoan parasite Leishmania donovani. Mol Pharm 74: 1292-1307.
30. Kupchan SM, Anderson WK, Bollinger P, Doskotch RW, Smith RM, Renauld JA, Schnoes HK, Burlingame AL, Smith DH, 1969. Tumor inhibitors. XXXIX. Active principles of Acnistus arborescens. Isolation and structural and spectral studies of with aferin A and with acristin. J Org Chem 34: 3858-3866.
31. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X, 1997. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90: 405-413. (Pubitemid 27347231)
32. Ariyanayagam MR, Fairlamb AH, 2001. Ovothiol and trypanothione as antioxidants in trypanosomatids. Mol Biochem Parasitol 115: 189-198. (Pubitemid 32566228)
33. Steenkamp DJ, 2002. Trypanosomal antioxidants and emerging aspects of redox regulation in the trypanosomatids. Antioxid Redox Signal 4: 105-121. (Pubitemid 34260691)
34. Bocedi A, Dawood KF, Fabrini R, Federici G, Gradoni L, Pedersen JZ, Ricci G, 2010. Trypanothione efficiently intercepts nitric oxide as a harmless iron complex in trypanosomatid parasites. FASEB J 24: 1035-1042.
35. Tovar J, Cunningham ML, Smith AC, Croft SL, Fairlamb AH, 1998. Down-regulation of Leishmania donovani trypanothione reductase by heterologous expression of a trans-dominant mutant homologue: effect on parasite intracellular survival. Proc Natl Acad Sci USA 95: 5311-5316. (Pubitemid 28208594)
36. Das M, Mukherjee SB, Shaha C, 2001. Hydrogen peroxide induces apoptosis-like death in Leishmania donovani promastigotes. J Cell Sci 114: 2461-2469. (Pubitemid 32684800)
37. Das R, Roy A, Dutta N, Majumder HK, 2008. Reactive oxygen species and imbalance of calcium homeostasis contributes to curcumin induced programmed cell death in Leishmania donovani. Apoptosis 13: 867-882.
38. Lee N, Bertholet S, Debrabant A, Muller J, Duncan R, Nakhasi HL, 2002. Programmed cell death in the unicellular protozoan parasite Leishmania. Cell Death Differ 9: 53-64. (Pubitemid 34071993)
39. Castanys-Munoz E, Brown E, Coombs GH, Mottram JV, 2012. Leishmania mexicana metacaspase is a negative regulator of amastigote proliferation in mammalian cells. Cell Death Dis 3: e385.
40. Moss CX, Westrop GD, Juliano L, Coombs GH, Mottram JC, 2007. Metacaspase 2 of Trypanosoma brucei is a calciumdependent cysteine peptidase active without processing. FEBS Lett 581: 5635-5639. (Pubitemid 350179768)